Oxford-AstraZeneca Vaccine in Question!

Pharmaceutical executives in the U.S. raised questions this week over the Oxford-AstraZeneca vaccine candidate putting into question the suitability of the vaccine for higher risk candidates.

The UK have 100 million doses on order with 4 million to be ready by December. Is this a ploy from the big US Pharmaceutical companies & what effect could this have on the Pound?

AstraZeneca shares have fallen 6% as a result!